Warfarin was associated with more risk than apixaban (Eliquis; 55.38 vs 21.42 per 1,000 person-years, HR 2.60, 95% CI ...

Cerebral venous thrombosis is a rare but potentially life-threatening condition that is particularly prevalent in young women (ie, mean age 44 years) and accounts for 0·5–3% of all strokes. The ...

Angiotensin-converting enzyme (ACE) inhibitors are oral medications that lower blood pressure. They are used to treat a variety of heart-related conditions including high blood pressure, coronary ...

DOACs are as effective and safe as warfarin—sometimes more so—and are far more straightforward to take. Dr. Mitchell said, "For example, apixaban (a DOAC) has a lower risk of significant ...

Vitamin K-inhibiting anticoagulants, especially warfarin, have become standard ... significant benefit with warfarin and other vitamin K inhibitors. The generalizability of these randomized ...

In the matched cohort, DOAC use (versus warfarin) was associated with a lower rate of ischemic ... antiplatelet agents, proton‐pump inhibitors, and statins), and measures of health care use (eg, ...

Adenosine deaminase inhibitors blocking inosine and hypoxanthine production abolished the inhibition of L-arginine on osteoclastogenesis in vitro and in vivo. Altered arginine levels were also found ...

Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, P. R. China State Key Laboratory of Chemical Biology, ...

Table 01: Global Anticoagulants Market Value (US$ Bn) Forecast, by Route of Administration, 2017-2031 Table 02: Global Anticoagulants Market Value (US$ Bn) Forecast, by Drug Class, 2017-2031 Table 03: ...

4F-PCC indicates 4 factor prothrombin complex concentrate; ANNEXA-4, Andexanet Alfa, a Novel Antidote to the Anticoagulation Effects of FXA Inhibitors; NOAC, novel oral anticoagulants; RE-VERSE AD, ...